The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).
 
Brian M. Shuch
Honoraria - Exelixis
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Histosonics; Johnson & Johnson/Janssen; Merck; Veracyte
 
Allan J. Pantuck
Leadership - Athos Therapeutics
Stock and Other Ownership Interests - Alimera Sciences; Athos Therapeutics; Kyn therapeutics; Medicus AI; Urogen pharma
Consulting or Advisory Role - 34Plus; Athos Therapeutics; Medicus AI; Pfizer; T Cure Bioscience
Research Funding - Telix Pharmaceuticals (Inst)
Expert Testimony - Breckenridge Pharmaceuticals
Travel, Accommodations, Expenses - Pfizer
 
Jean-Christophe Bernhard
Honoraria - BMS GmbH & Co. KG; Intuitive Surgical; MSD
Consulting or Advisory Role - Ipsen; MSD
Research Funding - ConMed; Intuitive Surgical
Travel, Accommodations, Expenses - BMS GmbH & Co. KG; Ipsen; Pfizer
 
Michael A. Morris
No Relationships to Disclose
 
Viraj A. Master
Honoraria - Ethicon; Exelixis
 
Andrew Mark Scott
Research Funding - Adalta (Inst); Antengene (Inst); AstraZeneca (Inst); AVID/Lilly (Inst); Curis (Inst); Cyclotek (Inst); EMD Serono (Inst); Fusion Pharmaceuticals (Inst); Humanigen (Inst); Isotopen Technologien (Inst); Merck (Inst); Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patents relating to antibodies to EGFR, HER2, PDGF-CC, FN-14, GM-CSF, EPhA3 (Inst)
 
Charles Van Praet
Honoraria - Astellas Pharma
Consulting or Advisory Role - Astellas Pharma; MercK
Travel, Accommodations, Expenses - Ipsen
 
Clément Bailly
Consulting or Advisory Role - Boston Scientific; Sirtex Medical
 
Tamer Aksoy
Honoraria - Telix Pharmaceuticals (Inst)
Research Funding - Telix Pharmaceuticals
 
Robin Merkx
Research Funding - Telix Pharmaceuticals (Inst)
 
David M. Schuster
Employment - Ascend Imaging (I)
Consulting or Advisory Role - DuChemBio; Global Medical Solutions; Progenics
Research Funding - Advanced Accelerator Applications (Inst); Amgen (Inst); Blue Earth Diagnostics (Inst); FUJIFILM (Inst); Nihon Medi-Physics (Inst); Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Inventor(s): Miller, Matthew (Oxford, GB), Gauden, David (Oxford, GB), Schuster, David (Atlanta, GA), Fanti, Stefano (Bologna, IT), Nanni, Cristina (Bologna, IT), Zanoni, Lucia (Bologna, IT), Willoch, Frode (Oslo, NO), Bogsrud, Trond Velde (Oslo, NO), Bac
Other Relationship - PrecisCa; School of Breast Oncology
 
Sze Ting Lee
No Relationships to Disclose
 
Neeta Pandit-Taskar
Honoraria - Actinium Pharmaceuticals
Consulting or Advisory Role - Actinium Pharmaceuticals; Fusion Pharmaceuticals; Illumina; progenics
Speakers' Bureau - Actinium Pharmaceuticals
Research Funding - Bayer Health (Inst); Bristol-Myers Squibb (Inst); Clarity Pharmaceuticals (Inst); Fusion Pharmaceuticals (Inst); Imaginab (Inst); Janssen (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Bayer
 
Libuse Tauchmanova
Employment - Telix Pharmaceuticals
Stock and Other Ownership Interests - Novartis
 
Phillip Allman
Employment - Premier Research
Consulting or Advisory Role - Premier Research (Inst)
 
Kavita Vadali
Employment - Telix Pharmaceuticals
Stock and Other Ownership Interests - Telix Pharmaceuticals
 
Colin Hayward
Employment - Telix Pharmaceuticals
 
Peter Mulders
No Relationships to Disclose